VNDA
Vanda Pharmaceuticals Inc
NASDAQ: VNDA · HEALTHCARE · BIOTECHNOLOGY
$7.10
+0.71% today
Updated 2026-04-30
Market cap
$411.32M
P/E ratio
—
P/S ratio
1.90x
EPS (TTM)
$-3.74
Dividend yield
—
52W range
$4 – $10
Volume
2.8M
Vanda Pharmaceuticals Inc (VNDA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |